Product Information
Cymbalta and GAD
Patients with generalized anxiety disorder (GAD) have excessive anxiety and worry, occuring more days than not for at least 6 months, about a number of events or activities. Patients with GAD often find it difficult to control their excessive anxiety or worry, and these symptoms are accompanied by at least 3 of the following: restlessness, becoming easily fatigued, difficulty concentrating, irritability, muscle tension, and disturbed sleep. These symptoms cause clinically significant distress or impairment with work, social, or other important areas of functioning.1
Cymbalta Demonstrated Improvement in Patients With GAD
- Demonstrated Improvement: In clinical trials of GAD, Cymbalta significantly reduced anxious symptoms and improved functioning in patients with GAD2-7
- Safety and tolerability: Learn about treatment-emergent adverse events associated with Cymbalta and GAD
- Simplicity: Cymbalta offers simple once-daily dosing8
References:
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, Text Revision; Washington, DC; American Psychiatric Association; 2000.
- Data on file, Lilly Research Laboratories: CYM20090505F.
- Koponen H, et al. (Prim Care Companion) J Clin Psychiatry. 2007;9(2):100-107.
- Rynn M, et al. Depress Anxiety. 2008;25(3):182-189.
- Hartford J, et al. Int Clin Psychopharmacol. 2007;22(3):167-174.
- Endicott J, et al. J Clin Psychiatry. 2007;68(4):518-524.
- Nicolini H, et al. Psychol Med. 2009;39(2):267-276.
- Cymbalta full Prescribing Information, 2009.
Formulary Access Finder
Cymbalta has been added to the Anthem Blue Cross Blue Shield National Preferred Formulary.
Get more information about the formulary access for Cymbalta. Download PDF files of insurance providers covering Cymbalta in your state.
Register to Receive Information From Cymbalta
Keep up-to-date on the latest developments with Cymbalta. Sign up now for our periodic emails.







